H.I.G. Capital Expands in Healthcare with Strategic Acquisitions
H.I.G. Capital, a prominent alternative investment firm, is making significant strides in the healthcare sector with a series of strategic acquisitions and partnerships. Known for managing over $65 billion in assets, H.I.G. Capital is leveraging its financial prowess to tap into high-growth industries, reinforcing its commitment to the healthcare market.
Recently, H.I.G. Capital completed the acquisition of SkinCure Oncology. This Illinois-based company specializes in non-invasive cancer treatments, particularly using image-guided superficial radiation therapy for nonmelanoma skin cancer. This acquisition aligns with the growing trend towards non-invasive medical solutions, marking a noteworthy expansion for H.I.G. Capital in the healthcare domain.
In addition to healthcare, H.I.G. Capital has shown interest in adjacent sectors that support healthcare infrastructure. Its acquisition of Action Elevator highlights this strategy. Action Elevator, a company dedicated to elevator maintenance and modernization, plays a crucial role in ensuring the efficient operation of healthcare facilities. By investing in such infrastructure services, H.I.G. Capital strengthens its position across interconnected industries.
Moreover, the sale of BIOVECTRA, a CDMO specializing in pharmaceutical ingredients, to Agilent Technologies for $925 million underscores H.I.G. Capital’s ability to identify and capitalize on lucrative exit opportunities. Under H.I.G.’s stewardship, BIOVECTRA saw significant growth, reinforcing the firm’s knack for nurturing and scaling businesses within its portfolio.
These moves by H.I.G. Capital reveal a strategic approach that combines acquisitions in both healthcare and its supporting industries. As the firm continues to diversify its holdings, it remains a key player in shaping the future landscape of these sectors. H.I.G. Capital’s ongoing efforts reflect its dedication to seizing opportunities in promising markets, ensuring sustainable growth and innovation.